Literature DB >> 5100423

The thalidomide tragedy in Germany: the end of a historic medicolegal trial.

W J Curran.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5100423     DOI: 10.1056/NEJM197103042840906

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

Review 2.  Ethical issues in including pediatric cancer patients in drug development trials.

Authors:  Katarina Aleksa; Gideon Koren
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Clinical trials in children.

Authors:  Pathma D Joseph; Jonathan C Craig; Patrina H Y Caldwell
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.

Authors:  Antje Neubert; Harald Dormann; Hans-Ulrich Prokosch; Thomas Bürkle; Wolfgang Rascher; Reinhold Sojer; Kay Brune; Manfred Criegee-Rieck
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

Review 5.  Trial Watch: Lenalidomide-based immunochemotherapy.

Authors:  Michaela Semeraro; Erika Vacchelli; Alexander Eggermont; Jerome Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

6.  Novel insights into the mechanism of action of lenalidomide.

Authors:  Michaela Semeraro; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-02-01       Impact factor: 8.110

Review 7.  Classification of current anticancer immunotherapies.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; José-Manuel Bravo-San Pedro; Aitziber Buqué; Laura Senovilla; Elisa Elena Baracco; Norma Bloy; Francesca Castoldi; Jean-Pierre Abastado; Patrizia Agostinis; Ron N Apte; Fernando Aranda; Maha Ayyoub; Philipp Beckhove; Jean-Yves Blay; Laura Bracci; Anne Caignard; Chiara Castelli; Federica Cavallo; Estaban Celis; Vincenzo Cerundolo; Aled Clayton; Mario P Colombo; Lisa Coussens; Madhav V Dhodapkar; Alexander M Eggermont; Douglas T Fearon; Wolf H Fridman; Jitka Fučíková; Dmitry I Gabrilovich; Jérôme Galon; Abhishek Garg; François Ghiringhelli; Giuseppe Giaccone; Eli Gilboa; Sacha Gnjatic; Axel Hoos; Anne Hosmalin; Dirk Jäger; Pawel Kalinski; Klas Kärre; Oliver Kepp; Rolf Kiessling; John M Kirkwood; Eva Klein; Alexander Knuth; Claire E Lewis; Roland Liblau; Michael T Lotze; Enrico Lugli; Jean-Pierre Mach; Fabrizio Mattei; Domenico Mavilio; Ignacio Melero; Cornelis J Melief; Elizabeth A Mittendorf; Lorenzo Moretta; Adekunke Odunsi; Hideho Okada; Anna Karolina Palucka; Marcus E Peter; Kenneth J Pienta; Angel Porgador; George C Prendergast; Gabriel A Rabinovich; Nicholas P Restifo; Naiyer Rizvi; Catherine Sautès-Fridman; Hans Schreiber; Barbara Seliger; Hiroshi Shiku; Bruno Silva-Santos; Mark J Smyth; Daniel E Speiser; Radek Spisek; Pramod K Srivastava; James E Talmadge; Eric Tartour; Sjoerd H Van Der Burg; Benoît J Van Den Eynde; Richard Vile; Hermann Wagner; Jeffrey S Weber; Theresa L Whiteside; Jedd D Wolchok; Laurence Zitvogel; Weiping Zou; Guido Kroemer
Journal:  Oncotarget       Date:  2014-12-30

8.  Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes.

Authors:  Axel Newe; Stefan Wimmer; Antje Neubert; Linda Becker; Hans-Ulrich Prokosch; Matthias W Beckmann; Rainer Fietkau; Christian Forster; Markus Friedrich Neurath; Georg Schett; Thomas Ganslandt
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  Dramatyping: a generic algorithm for detecting reasonable temporal correlations between drug administration and lab value alterations.

Authors:  Axel Newe
Journal:  PeerJ       Date:  2016-03-24       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.